397 related articles for article (PubMed ID: 25811757)
21. What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
Joseph SB; Trunfio M; Kincer LP; Calcagno A; Price RW
AIDS; 2019 Dec; 33 Suppl 2():S171-S179. PubMed ID: 31790378
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Macrophage-Tropic HIV-1 Infection of Central Nervous System Cells and the Influence of Inflammation.
Woodburn BM; Kanchi K; Zhou S; Colaianni N; Joseph SB; Swanstrom R
J Virol; 2022 Sep; 96(17):e0095722. PubMed ID: 35975998
[TBL] [Abstract][Full Text] [Related]
23. Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications.
Gonzalez-Perez MP; Peters PJ; O'Connell O; Silva N; Harbison C; Cummings Macri S; Kaliyaperumal S; Luzuriaga K; Clapham PR
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768859
[TBL] [Abstract][Full Text] [Related]
24. Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus.
Kincer LP; Joseph SB; Gilleece MM; Hauser BM; Sizemore S; Zhou S; Di Germanio C; Zetterberg H; Fuchs D; Deeks SG; Spudich S; Gisslen M; Price RW; Swanstrom R
Nat Microbiol; 2023 Feb; 8(2):260-271. PubMed ID: 36717718
[TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 target cells in the CNS.
Joseph SB; Arrildt KT; Sturdevant CB; Swanstrom R
J Neurovirol; 2015 Jun; 21(3):276-89. PubMed ID: 25236812
[TBL] [Abstract][Full Text] [Related]
28. Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy.
Gianella S; Kosakovsky Pond SL; Oliveira MF; Scheffler K; Strain MC; De la Torre A; Letendre S; Smith DM; Ellis RJ
Virus Evol; 2016 Jul; 2(2):vew020. PubMed ID: 27774305
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
[TBL] [Abstract][Full Text] [Related]
30. CSF, plasma viral load and HIV associated dementia.
Robertson K; Fiscus S; Kapoor C; Robertson W; Schneider G; Shepard R; Howe L; Silva S; Hall C
J Neurovirol; 1998 Feb; 4(1):90-4. PubMed ID: 9531015
[TBL] [Abstract][Full Text] [Related]
31. Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties.
Stefic K; Chaillon A; Bouvin-Pley M; Moreau A; Braibant M; Bastides F; Gras G; Bernard L; Barin F
PLoS One; 2017; 12(8):e0181680. PubMed ID: 28841647
[TBL] [Abstract][Full Text] [Related]
32. Characterization of HIV variants from paired Cerebrospinal fluid and Plasma samples in primary microglia and CD4
Gumbs SBH; Stam AJ; Mudrikova T; Schipper PJ; Hoepelman AIM; van Ham PM; Borst AL; Hofstra L; Gharu L; van Wyk S; Wilkinson E; de Witte LD; Wensing AMJ; Nijhuis M
J Neurovirol; 2024 May; ():. PubMed ID: 38713307
[TBL] [Abstract][Full Text] [Related]
33. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities.
Conrad AJ; Schmid P; Syndulko K; Singer EJ; Nagra RM; Russell JJ; Tourtellotte WW
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):425-35. PubMed ID: 7583438
[TBL] [Abstract][Full Text] [Related]
34. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations.
Smith DM; Zárate S; Shao H; Pillai SK; Letendre SL; Wong JK; Richman DD; Frost SD; Ellis RJ;
Virology; 2009 Mar; 385(1):204-8. PubMed ID: 19100592
[TBL] [Abstract][Full Text] [Related]
35. Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system.
Price RW; Deeks SG
J Neurovirol; 2004; 10 Suppl 1():44-51. PubMed ID: 14982739
[TBL] [Abstract][Full Text] [Related]
36. Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics.
de Almeida SM; Oliveira MF; Chaillon A; Rotta I; Ribeiro CE; de Pereira AP; Smith D; Letendre S; Ellis RJ
J Neurovirol; 2018 Dec; 24(6):786-796. PubMed ID: 30194587
[TBL] [Abstract][Full Text] [Related]
37. Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals.
De Luca A; Ciancio BC; Larussa D; Murri R; Cingolani A; Rizzo MG; Giancola ML; Ammassari A; Ortona L
Neurology; 2002 Aug; 59(3):342-7. PubMed ID: 12177366
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients.
Antinori A; Giancola ML; Grisetti S; Soldani F; Alba L; Liuzzi G; Amendola A; Capobianchi M; Tozzi V; Perno CF
AIDS; 2002 Sep; 16(14):1867-76. PubMed ID: 12351946
[TBL] [Abstract][Full Text] [Related]
39. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.
Staprans S; Marlowe N; Glidden D; Novakovic-Agopian T; Grant RM; Heyes M; Aweeka F; Deeks S; Price RW
AIDS; 1999 Jun; 13(9):1051-61. PubMed ID: 10397535
[TBL] [Abstract][Full Text] [Related]
40. Analysis of correlation between cerebrospinal fluid and plasma HIV-1 RNA levels in patients with neurological opportunistic diseases.
Christo PP; Greco DB; Aleixo AW; Livramento JA
Rev Inst Med Trop Sao Paulo; 2011; 53(4):193-6. PubMed ID: 21915461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
